Trium Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,933
Closed -$5.5M 45
2024
Q3
$5.5M Sell
24,933
-46
-0.2% -$9.52K 1.57% 10
2024
Q2
$4.91M Sell
24,979
-5,234
-17% -$1.08M 0.62% 16
2024
Q1
$6.5M Buy
30,213
+839
+3% +$176K 2.44% 15
2023
Q4
$6.19K Buy
29,374
+1,517
+5% +$324K 0.5% 15
2023
Q3
$5.58K Buy
27,857
+1,576
+6% +$313K 0.1% 18
2023
Q2
$4.87K Sell
26,281
-2,559
-9% -$473K 1.04% 25
2023
Q1
$5.52M Buy
28,840
+761
+3% +$138K 1.91% 17
2022
Q4
$4.72M Buy
+28,079
New +$4.88M 1.74% 24

Other funds holding CME

Trium Capital's CME Position: Q4 2024 in Review

Trium Capital sold out of CME Group (CME) in Q4 2024, closing a stake of 24,933 shares — an estimated $5.5M sold.

Trium Capital first reported a position in CME in Q4 2022 and held it in 8 quarters. The position peaked at $6.5M in Q1 2024. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

  • Trium Capital reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
  • Trium Capital sold 24,933 CME Group shares in Q4 2024, an estimated $5.5M.
  • Trium Capital first reported a position in CME Group in Q4 2022 and held it in 8 quarters.
  • Trium Capital's CME Group position peaked at $6.5M in Q1 2024.
  • 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Trium Capital's 13F filing for Q4 2024, filed 15 Jan 2025.